Publikationen
Unsere Forschungsergebnisse erscheinen in internationalen Publikationen in Peer-Reviewed Journals, außerdem in Kongressbeiträgen, Vorträgen und Postern und wissenschaftlichen Fachveranstaltungen.
Übersicht über unsere Publikationen
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database
Bewersdorf JP, Kewan T, Lanino L, Wei W, Rudra Gupta T, Stempel JM, Al Ali NH, DeZern AE, Sekeres MA, Uy GL, Urrutia S, Carraway HE, Desai P, Griffiths EA, Stein EM, Brunner AM, McMahon C, Shallis RM, Zeidner JF, Savona MR, Hawkins H, Chandhok NS, Logothetis CN, Bidikian A, Getz TM, Roboz GJ, Rolles B, Wang ES, Harris AC, Amaya ML, Ball S, Grenet J, Xie Z, Madanat YF, Abaza Y, Badar T, Campos J, Haferlach T, Maciejewski JP, Sallman D, Enjeti A, Al-Rabi K, Halahleh K, Hiwase D, Diez-Campelo M, Valcarcel D, Haferlach C, Pleyer L, Kotsianidis I, Pappa V, Santini V, Consagra A, Al-Kali A, Ogawa S, Nannya Y, Stahl M, Della Porta MG, Komrokji RS, Zeidan AM. Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database. Blood Cancer J. 2026.
Mehr erfahrenPan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells
Barcelo J, Teigen Y, Martin JAJ, George S, Das D, Sewell J, Perdrix-Rosell A, Bewicke-Copley F, Ghose R, Yang W, Brough R, Clear A, Walter W, Haferlach T, Malanchi I, Gribben JG, van de Lagemaat LN, Kranc KR, Lord CJ, Rio-Machin A, Maiques O, Fitzgibbon J, Sanz-Moreno V. Pan-cancer analysis reveals Rho kinase addiction as a vulnerability of de-differentiated cancer cells. iScience. 2026.
Mehr erfahrenReal-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)
Maggioni G, Todisco G, Sauta E, Lanino L, Ball S, Bewersdorf JP, Kewan T, Al Ali NH, Fenaux P, Platzbecker U, Santini V, Xie Z, Brunner AM, Kuykendall AT, Bennett JM, Buckstein R, Bejar R, Carraway HE, DeZern AE, Griffiths EA, Halene S, Hasserjian RP, List AF, Loghavi S, Odenike O, Padron E, Patnaik MM, Roboz GJ, Stahl M, Sekeres MA, Steensma DP, Savona MR, Taylor J, Xu ML, Sallman DA, Nimer SD, Hourigan CS, Wei AH, Campagna A, Ubezio M, Riva E, Ventura D, Pinocchio N, Zampini M, Buizza A, Russo A, Pesce F, D'Amico S, Asti G, Delleani M, Travaglino E, Tentori CA, Ferrari I, Crespi A, Figini G, Di Matteo M, Brindisi M, Manes N, Milanesi C, Crisafulli L, Ficara F, Castellani G, Borate UM, Efficace F, Gore SD, Kim TK, Diez-Campelo M, van de Loosdrecht AA, Daver N, Rozman M, Orfao A, Wang SA, Foucar K, Iastrebner M, Scheinberg P, Miyazaki Y, Madanat YF, Al-Kali A, Mittelmann M, Cluzeau T, Ades L, Germing U, Garcia-Manero G, Kordasti S, Haferlach T, Zeidan AM, Komrokji RS, Della Porta MG. Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS). Hemasphere. 2026.
Mehr erfahrenAdult TWIST2-high B-ALL confirms metabolic association but reveals molecular heterogeneity. Hemasphere
Walter W, Ecker V, Kern W, Stengel A. Adult TWIST2-high B-ALL confirms metabolic association but reveals molecular heterogeneity. Hemasphere. 2026.
Mehr erfahrenAllogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome
Mohring A, Sockel K, Thiede C, Schröder J, Wolff D, Kadantsev M, Werth M, Schneider M, Globuschuetz T, Franke GN, Klein S, Göthert J, Claassen CH, Bug G, Reinhardt HC, Hecht-So A, Götze KS, Floßdorf S, Bethge W, Bornhäuser M, Schetelig J, Stelljes M, Haferlach T, Schroeder T, Rautenberg C. Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome. Transplant Cell Ther. 2026.
Mehr erfahrenComprehensive landscape of secondary cytogenetic and molecular genetic events in multiple myeloma patients at diagnosis
Wobst J, Truger M, Wossidlo N, Hutter S, Meggendorfer M, Kern W, Haferlach T, Haferlach C. Comprehensive landscape of secondary cytogenetic and molecular genetic events in multiple myeloma patients at diagnosis. Leukemia. 2026.
Mehr erfahrenNot Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T-Cell Acute Lymphoblastic Leukemia
Beas F, Hutter S, Balbastre-Úbeda F, Novoa-Jáuregui S, Gabarrós-Subirà M, Genescà E, Pölönen P, Haferlach T, Jerez A. Not Missing the Notch: Detection Challenges of Juxtamembrane NOTCH1 Variant Detection in T-Cell Acute Lymphoblastic Leukemia. J Clin Lab Anal. 2026.
Mehr erfahren